Literature DB >> 26337378

Cross-Talk Between Mesenchymal Stem/Stromal Cells and Dendritic Cells.

Jelena M Ðokić, Sergej Z Tomić, Miodrag J Čolić1.   

Abstract

Mesenchymal stem/stromal cells (MSCs, having both multi-potent differentiation potential and prominent immunomodulatory properties, are seen as a very powerful tool for the therapy of diseases characterized by tissue damage and/or unregulated immune responses. Dendritic cells (DCs are key immunoregulatory cells at the crossroads between immunity and tolerance, able to fine-tune the whole immune response via regulation of adaptive immunity. Therefore, untangling the complex interactions between DCs and MSCs is crucial for understanding various mechanisms involved in the pathogenesis of immune-related diseases and for the discovery of new therapeutic targets for advanced treatment procedures. From this perspective, we reviewed the data that have been obtained to date regarding the complex effects of MSCs on DC development and functions, delineating the abundant mechanisms involved in these interactions. Additionally, we have pointed out to additional mechanisms of MSC/DC cross-talk that have not been directly proven, but that could have a significant role, not only in DC functions and the maintenance of immune homeostasis, but also in migration, differentiation and the functions of MSCs. For now, much more is known about the influence of MSCs on DCs than vice versa, so more studies should be done in order to fully understand this cross-talk.

Mesh:

Year:  2016        PMID: 26337378

Source DB:  PubMed          Journal:  Curr Stem Cell Res Ther        ISSN: 1574-888X            Impact factor:   3.828


  10 in total

1.  Bone Marrow Mesenchymal Stem Cells Inhibit the Function of Dendritic Cells by Secreting Galectin-1.

Authors:  Yue Zhang; Xia-Hui Ge; Xue-Jun Guo; Si-Bin Guan; Xiao-Ming Li; Wen Gu; Wei-Guo Xu
Journal:  Biomed Res Int       Date:  2017-06-21       Impact factor: 3.411

2.  Adaptive Regulation of Osteopontin Production by Dendritic Cells Through the Bidirectional Interaction With Mesenchymal Stromal Cells.

Authors:  Sara Scutera; Valentina Salvi; Luisa Lorenzi; Giorgia Piersigilli; Silvia Lonardi; Daniela Alotto; Stefania Casarin; Carlotta Castagnoli; Erica Dander; Giovanna D'Amico; Silvano Sozzani; Tiziana Musso
Journal:  Front Immunol       Date:  2018-06-01       Impact factor: 7.561

Review 3.  Clinical Applications of Mesenchymal Stem/Stromal Cell Derived Extracellular Vesicles: Therapeutic Potential of an Acellular Product.

Authors:  Margherita Massa; Stefania Croce; Rita Campanelli; Carlotta Abbà; Elisa Lenta; Chiara Valsecchi; Maria Antonietta Avanzini
Journal:  Diagnostics (Basel)       Date:  2020-11-24

Review 4.  Mesenchymal stromal cell-dependent immunoregulation in chemically-induced acute liver failure.

Authors:  Jia-Hang Zhou; Xuan Lu; Cui-Lin Yan; Xin-Yu Sheng; Hong-Cui Cao
Journal:  World J Stem Cells       Date:  2021-03-26       Impact factor: 5.326

Review 5.  Stem cell therapy: A promising treatment for COVID-19.

Authors:  Zhi-Xue Zheng
Journal:  World J Clin Cases       Date:  2021-12-26       Impact factor: 1.337

Review 6.  Mesenchymal Stem/Stromal Cells and Their Paracrine Activity-Immunomodulation Mechanisms and How to Influence the Therapeutic Potential.

Authors:  Rui Alvites; Mariana Branquinho; Ana C Sousa; Bruna Lopes; Patrícia Sousa; Ana Colette Maurício
Journal:  Pharmaceutics       Date:  2022-02-09       Impact factor: 6.321

Review 7.  Targeted Therapy for Inflammatory Diseases with Mesenchymal Stem Cells and Their Derived Exosomes: From Basic to Clinics.

Authors:  Shuo Wang; Biyu Lei; E Zhang; Puyang Gong; Jian Gu; Lili He; Lu Han; Zhixiang Yuan
Journal:  Int J Nanomedicine       Date:  2022-04-19

Review 8.  Mesenchymal Stem Cells as New Therapeutic Agents for the Treatment of Primary Biliary Cholangitis.

Authors:  Aleksandar Arsenijevic; C Randall Harrell; Crissy Fellabaum; Vladislav Volarevic
Journal:  Anal Cell Pathol (Amst)       Date:  2017-12-19       Impact factor: 2.916

Review 9.  Stem cell therapy for COVID-19, ARDS and pulmonary fibrosis.

Authors:  Zhongwen Li; Shuaishuai Niu; Baojie Guo; Tingting Gao; Lei Wang; Yukai Wang; Liu Wang; Yuanqing Tan; Jun Wu; Jie Hao
Journal:  Cell Prolif       Date:  2020-10-24       Impact factor: 6.831

Review 10.  Immunomodulatory Effect of MSCs and MSCs-Derived Extracellular Vesicles in Systemic Lupus Erythematosus.

Authors:  Chunjuan Yang; Jianmei Sun; Yipeng Tian; Haibo Li; Lili Zhang; Jinghan Yang; Jinghua Wang; Jiaojiao Zhang; Shushan Yan; Donghua Xu
Journal:  Front Immunol       Date:  2021-09-16       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.